Truly Technologies develops bioprocessing solutions that isolate biomolecules using osmotic pressure differences across a semipermeable membrane. This technology simultaneously concentrates and purifies target biomolecules from complex biospecimens with high yield. The scalable, power-free device supports applications ranging from diagnostic biomarker concentration to therapeutic nanoparticle purification.
Funding
$30K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many diagnostic and therapeutic applications struggle with low biomarker concentrations and unwanted sample content in biospecimens, hindering efficient processing and analysis. Traditional methods often require complex steps and specialized equipment, limiting their accessibility and scalability.
Solution
Truly Technologies offers a biospecimen processing device that leverages osmotic pressure differences across a semipermeable membrane to concentrate and purify biomolecules. This technology enables efficient isolation of biomolecules at high yield and purity, addressing challenges in both diagnostic biomarker concentration and therapeutic nanoparticle purification. The device's design spreads the biofluid specimen into an ultra-thin layer, facilitating rapid diffusion of water molecules and small particles across the membrane. The membrane pore size is selectable to retain specific biomolecules, and the device is scalable to accommodate microliter-to-liter volumes. The concentration and purification process occurs spontaneously without a power source, simplifying the workflow.
Target Audience
The primary audience includes in-vitro diagnostics companies, therapeutic processing facilities, and laboratory research institutions seeking efficient and scalable bioprocessing solutions.
Features
- Osmotic pressure-driven concentration and purification of biomolecules
- Semi-permeable membrane with selectable pore size for targeted biomolecule retention
- Ultra-thin fluid layer design for rapid diffusion and efficient processing
- Scalable device accommodating microliter-to-liter sample volumes
- Spontaneous, power-free operation for simplified workflow
- Customizable device form factor tailored to specific use cases
- Integration-ready sample collection mechanism for seamless downstream processing